Neurotech Reports

The Orion visual neuroprosthetic system, originally developed by Second Sight Medical Products, is changing parent companies again, Neurotech Reports said. Vivani Medical has agreed a reverse merger with Nasdaq-listed ClearOne under which its Cortigent unit becomes a wholly owned ClearOne subsidiary; ClearOne will be renamed Cortigent Holdings Inc. and is expected to trade as CRGT. ClearOne agreed as part of the transaction to file a Form S-1 registration statement to raise $10 million to $15 million, and Cortigent plans a pivotal trial of Orion in about 60 patients, though funding remains a challenge.

The second annual Neurotech Leaders Forum drew executives, investors, researchers and regulators from Europe and the United States to imec's campus in Leuven, Belgium, on June 23-24, 2026, for sessions on clinical translation, capital formation, regulatory strategy and emerging frontiers. Thomas Stieglitz of the University of Freiburg gave the Day 1 keynote, arguing for perseverance and functionalist design, and later sessions covered women's health, European BCI ventures and the region's capital and regulatory challenges. Companies showing new work included WISE SpA, with its Heron spinal cord stimulation lead, and Melora Medical, with a transcutaneous auricular vagus nerve stimulation (taVNS) device for dermatology.